Die Information für Ärzte und Apotheker
Neutral, unabhängig und anzeigenfrei

STARTSEITE
Impressum
Datenschutz
 
 
arznei-telegramm®  07/2018

SPOT ON
Priority for generic names (INN) … also on drug packages

NEW ON THE MARKET
Bezlotoxumab (ZINPLAVA) for recurrence prevention of Clostridium difficile associated diarrhea
Rosuvastatin plus ezetimibe (ANTILIA, ROSUZET)

a-t READERS QUESTIONS AND COMMENTS
Are cognitive impairment or dementia adverse effects of statins?
Vaccination in patients with hereditary fructose intolerance

IN BRIEF
Lenience towards the pharmaceutical industry – warnings on packages of over-the-counter analgesics

CURRENT ADR NETWORK REPORT
Withdrawal syndrome following discontinuation of venlafaxin (TREVILOR, generics)

SIDE EFFECTS
Multiple vertebral fractures after discontinuation of denosumab as XGEVA
Uterine fibroids: new restrictions of use for ulipristal acetate (ESMYA)


© arznei-telegramm